Patent · US Active

Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

US8686011B2 · kind B2 · utility

3Cited by

8References

5Claims

0Family size

Assignees

AMGEN INC. · US
Biovitrum AB · SE

Inventors

Martin Henriksson · Stockholm, SE
Evert Homan · Sollentuna, SE
Lars Johansson · Bromma, SE
Jerk Vallgarda · Uppsala, SE
Meredith Williams · Singapore, SG
Eric A. Bercot · Bend, US
Christopher H. Fotsch · Thousand Oaks, US
Aiwen Li · Westlake Village, US
Guolin Cai · Guilford, US
Randall W. Hungate · Lansdale, US
Chester Chenguang Yuan · Newbury Park, US
Christopher M. Tegley · Thousand Oaks, US
David J. St. Jean, Jr. · Camarillo, US
Nianhe Han · Newbury Park, US
Qi Huang · Moorpark, US
Qingyian Liu · Camarillo, US
Michael D. Bartberger · West Hollywood, US
George A. Moniz · Cambridge, US
Matthew J. Frizzle · Dundas, CA

Key dates

Filing date	Sep 15, 2011
Grant date	Apr 1, 2014
Priority date	—
Expiry date	Sep 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds with the formula (I), (II), (III) or (IV):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.